Press release
Pemphigus Vulgaris Treatment Market Expands with Novel Anti-CD20 Antibody Approvals in 2025 | F. Hoffmann-La Roche Ltd, Pfizer Inc, Teva Pharmaceutical Industries
Pemphigus Vulgaris Treatment
The Pemphigus Vulgaris treatment market features a strong lineup of pharmaceutical leaders and emerging biotech innovators. Roche, Pfizer, Novartis, Sanofi, AbbVie, and AstraZeneca dominate with their biologic and immunomodulatory portfolios. Teva, GSK, and Zydus Group bolster the market with generic therapies and biosimilars. Meanwhile, Syntimmune is advancing FcRn inhibitor platforms, rounding out a competitive landscape driven by R&D investment and differentiated therapy offerings.
Download your exclusive sample report today: https://www.datamintelligence.com/download-sample/pemphigus-vulgaris-treatment-market?jd
Pemphigus Vulgaris Treatment Market M&A & Strategic Collaborations
1. Roche-Syntimmune FcRn Inhibitor Licensing Deal
In June 2025, Roche secured global rights to Syntimmune's FcRn-blocking antibody for pemphigus, aiming to fast-track development through a strategic licensing collaboration.
2. Pfizer Acquires Dermatology Biotech Skintera Therapeutics
In May 2025, Pfizer completed its acquisition of Skintera to enhance its dermatology pipeline with novel anti-inflammatory biologics targeting pemphigus.
3. AbbVie-Zydus Biosimilar Partnership for Rituximab in PV
In July 2025, AbbVie formed a partnership with Zydus to develop and commercialize rituximab biosimilars for autoimmune skin disorders, with pemphigus vulgaris as a core indication.
As per our analysis, these developments reflect the industry pivot toward strategic licensing, targeted acquisitions, and biologic innovation, bolstering treatment pipelines and global access for PV patients.
Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/pemphigus-vulgaris-treatment-market?jd
Key Growth Drivers & Emerging Opportunities in the Pemphigus Vulgaris Market
• Shift toward biologics and specialty immunotherapies, such as anti-CD20 and FcRn inhibitors
• Regulatory support for orphan drugs and accelerated approval pathways
• Rising disease awareness and improved diagnostic capabilities among dermatologists
• Emergence of biosimilars, driving affordability and wider access to therapies
• Strategic collaborations between big pharma and biotech, enabling global development and distribution
Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=pemphigus-vulgaris-treatment-market?jd
Regional Market Drivers for Pemphigus Vulgaris Treatment
North America leads with proactive diagnosis, reimbursement for biologics, and robust clinical trial presence.
Europe benefits from orphan drug incentives, broader insurance coverage, and multi-country healthcare frameworks.
Asia-Pacific is rapidly advancing with expanding dermatologist networks, rising healthcare funding, and regulatory alignment on biologics.
Latin America and the Middle East & and Africa are emerging markets where international partnerships and access programs support market growth.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries, catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pemphigus Vulgaris Treatment Market Expands with Novel Anti-CD20 Antibody Approvals in 2025 | F. Hoffmann-La Roche Ltd, Pfizer Inc, Teva Pharmaceutical Industries here
News-ID: 4104905 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
Taiwan Probiotic Food Market Outlook 2024-2027: Clean-Label, Organic, and Functi …
The Taiwan Probiotic Food Market recorded a value of US$ 498.55 million in 2023 and is expected to reach a value of US$ 620.04 million in 2027, growing at a CAGR of 5.72% during the forecast period (2024-2027).
Taiwan's Probiotic Food Market includes fermented products and functional foods with live beneficial microorganisms. Growth is driven by digestive health awareness, immunity-boosting trends, and aging population needs. Products include yogurt, kefir, and dietary…
Germany Medical Technology market reached US$ 42.2 billion in 2023 and is expect …
The Germany Medical Technology market reached US$ 42.2 billion in 2023 and is expected to reach US$ 62.63 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
Germany's Medical Technology Market encompasses devices, diagnostic equipment, and digital health solutions. Growth is driven by aging populations, chronic disease prevalence, and healthcare innovation. Hospitals, clinics, and research centers are major end-users. Innovations focus on minimally invasive devices, AI…
Biopesticides Market Projected to Reach US$24.16B by 2032, Growing at a CAGR of …
The Biopesticides Market was valued at US$ 7,734.43 million in 2024 and is projected to reach US$ 24,158.10 million by 2032, registering a CAGR of 15.3% during the forecast period 2025-2032.
The market focuses on the development and use of biological pest control solutions derived from natural organisms, including microorganisms, plant extracts, and bioactive compounds. Biopesticides are widely applied in agriculture, horticulture, and forestry to control pests, enhance crop protection, and…
Japan Wearable Devices Market to Hit $12.31 Billion by 2033, Growing at 12.6% CA …
The Japan wearable devices market reached US$4,026.98 million in 2024 and is expected to reach US$12,310.52 million by 2033, growing at a CAGR of 12.6 % during the forecast period 2025-2033, according to DataM intelligence.
Japan's Wearable Devices Market includes smartwatches, fitness trackers, health monitors, and AR/VR devices. Growth is driven by healthcare monitoring, fitness trends, and IoT adoption. Applications span personal wellness, remote patient monitoring, and industrial safety. Companies and…
More Releases for Pemphigus
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Pemphigus Vulgaris Treatment Market: Growth, Trends, and Market Dynamics
Introduction
Pemphigus vulgaris is a rare autoimmune disorder characterized by painful blisters and erosions on the skin and mucous membranes. It occurs when the immune system mistakenly attacks the proteins that hold skin cells together, leading to severe dermatological issues. Without proper treatment, pemphigus vulgaris can lead to significant morbidity and complications. Over the years, advancements in medical research have improved treatment options, driving the growth of the global pemphigus vulgaris…
NA Pemphigus Vulgaris Market 2024 To Witness Amazing Growth By 2032
NA Pemphigus Vulgaris Market Size 2024[Latest Report]:
The North America pemphigus vulgaris market is expected to reach USD 313.87 million by 2030 from USD 165.49 million in 2022, growing at a CAGR of 8.4% during the forecast period of 2023 to 2030.
The NA Pemphigus Vulgaris Market 2024 Report makes available the current and forthcoming technical and financial details of the industry. This NA Pemphigus Vulgaris Market Report covers the Types, Applications,…
Pemphigus Vulgaris Market - A ray of hope for pemphigus vulgaris patients: our c …
Newark, New Castle, USA: The "Pemphigus Vulgaris Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Pemphigus Vulgaris Market: https://www.growthplusreports.com/report/pemphigus-vulgaris-market/8689
This latest report researches the industry structure, sales, revenue,…
Sweden Pemphigus Vulgaris Treatment Market Growth Analysis up to 2031
Pemphigus Vulgaris Treatment Market: Introduction
• Pemphigus Vulgaris is a rare autoimmune disorder characterized by painful blisters on the skin, lining of the mouth, throat, nose, and genitals. It usually affects the middle-aged population including both men and women. Pemphigus Vulgaris occurs when the body's own immune system mistakenly attacks proteins in the layer of the skin. The symptoms of pemphigus vulgaris include development of painful blisters and pinching sensation on the…
Global Pemphigus Vulgaris Market Research Report Forecast to 2027
Pemphigus Vulgaris Market 2020 comprises a detailed survey of the Pemphigus Vulgaris Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025.
Global "Pemphigus Vulgaris" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis.
The report mainly highlights the significant trends of the Pemphigus Vulgaris market in terms of thriving companies, business methods, product values and pricing, revenue,…
